• Bleomycin Sulfate: Practical Protocol Guide

  2026-09-21

  Bleomycin Sulfate (SKU A8331) provides a controllable DNA-damage stimulus for cytotoxicity, clastogenicity, and pulmonary fibrosis research. It is appropriate for qualified in vitro and in vivo model development, but dossier benchmarks should not be treated as universal potency values or as a substitute for route-specific validation.

• Sodium-Driven Mitochondrial Failure in NECSO

  2026-09-20

  Qiao and colleagues show that sodium overload does more than collapse plasma-membrane ion gradients: it directly disrupts mitochondrial calcium handling, oxidative phosphorylation, and the TCA cycle during necrosis by sodium overload (NECSO). The study provides a mechanistic framework for linking sodium influx to ATP failure, Na/K-ATPase dysfunction, cell swelling, and lysis, while suggesting that mitochondrial potential measurements should be interpreted alongside metabolic and ion-homeostasis readouts.

• Ibrexafungerp: Workflows for Resistant Candida

  2026-09-19

  Ibrexafungerp, also known as MK 3118, combines oral delivery with a glucan-synthase mechanism that can be investigated against fluconazole- and echinocandin-resistant Candida. This guide translates susceptibility testing, acidic-pH assays, and delayed-treatment animal studies into practical workflows with troubleshooting checkpoints.

• MALAT1–miR-125b–STAT3 Axis in Sepsis

  2026-09-18

  The reference study links the long noncoding RNA MALAT1 to procalcitonin expression in sepsis through a miR-125b/STAT3 regulatory axis. Its combination of patient samples, an LPS-stimulated U937 model, localization analysis, and interaction assays provides a mechanistic framework for interpreting PCT regulation beyond its use as a clinical biomarker.

• Cy3 TSA Fluorescence System Kit: Mechanism & Use

  2026-09-18

  The Cy3 TSA Fluorescence System Kit is a TSA fluorescence kit for HRP-mediated signal amplification in immunohistochemistry, immunocytochemistry, and in situ hybridization. It supports fluorescence microscopy detection of low-abundance biomolecules, but it does not replace target-specific assay controls or provide an intrinsic quantitative limit of detection.

• Human PSC Regionalization and Differentiation Potential

  2026-09-17

  The reference study shows that human pluripotent stem cell differentiation bias can arise from reversible anterior–posterior epiblast regionalization driven by locus-specific erosion of bivalent chromatin, rather than DNA methylation alone. Its chemical chromatin restoration approach re-established anterior epiblast-like transcriptional and chromatin states, improving neural organoid formation and broad germ-layer differentiation.

• Pheromone Signaling and Neurodegeneration in C. elegans

  2026-09-17

  Peng et al. reveal that pheromone exposure during the L1 developmental stage can reprogram neural circuitry and accelerate neurodegeneration later in adult C. elegans. The study maps a pathway from ASK and ASI chemosensory neurons through AIA interneurons to insulin-like signaling and neuronal autophagy, providing a mechanistic framework for studying how early environmental cues affect proteostasis.

• HyperFluor™ 594 Goat Anti-Rabbit IgG Guide

  2026-09-16

  HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody is a goat anti-rabbit IgG secondary antibody for fluorescence-based detection of rabbit primary antibodies. Its 590 nm excitation maximum, 617 nm emission maximum, affinity purification, and application-specific dilution guidance support immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA workflows.

• Dimethyloxalylglycine (DMOG) Protocol Guide

  2026-09-16

  Dimethyloxalylglycine (DMOG) is a cell-permeable, competitive PHD inhibitor used to support hypoxia-inducible factor stabilization under normoxic conditions. This guide covers preparation, controls, and quality checks for hypoxia signaling and inflammation research; DMOG is for scientific research only and is not intended for diagnostic, therapeutic, or medical use.

• NU7441 (KU-57788) for DNA-PK Research

  2026-09-15

  NU7441 (KU-57788) is a nanomolar-potency DNA-PK inhibitor for separating DNA repair effects from broader kinase signaling. This guide translates its biochemical selectivity into practical oncology, cell-cycle, and HIV-latency assay workflows, with troubleshooting for solubility, timing, and endpoint interpretation.

• Psora 4: Kv1.3 Blocker Workflow

  2026-09-15

  Psora 4 is a selective Kv1.3 blocker for connecting channel inhibition with T-cell calcium signaling, effector-memory responses, and inflammatory disease models. This practical guide covers compound preparation, kinetic assay design, selectivity controls, and troubleshooting for reproducible research use.

• MACC1–HNRNPH1 Control of IRAK1 Splicing in LUAD

  2026-09-14

  This study identifies a noncanonical role for MACC1 in lung adenocarcinoma: it promotes an oncogenic IRAK1 splice isoform by interacting with the splicing factor HNRNPH1. The findings connect MACC1 domains, HNRNPH1 recruitment, and exon 11-containing IRAK1 pre-mRNA to a regulatory pathway that may help explain how alternative splicing contributes to tumor progression.

• Dorsomorphin (Compound C): Mechanism & Uses

  2026-09-14

  Dorsomorphin, also called Compound C, is a reversible ATP-competitive AMPK inhibitor with additional activity against BMP signaling. Its dual pharmacology supports research on AMPK metabolism, autophagy regulation, iron metabolism modulation, and SMAD-dependent differentiation, but it requires pathway-specific controls.

• Deferasirox Fe3+ Chelate Assay Guide

  2026-09-13

  This scenario-based guide explains how Deferasirox Fe3+ chelate, SKU A3355, can support controlled iron-chelation experiments involving viability, proliferation, cytotoxicity, and myeloid differentiation. It separates product specifications from literature-derived mechanisms and provides practical controls for solvent handling, oxygen context, and data interpretation.

• Neddylation, SPOP, and Glutamine Metabolism in Cancer

  2026-09-12

  The reference study identifies CRL3SPOP-mediated degradation of the glutamine transporter ASCT2 as a mechanistic link between neddylation and cancer-cell metabolism. Its genetic, biochemical, cellular, animal, and patient-sample data support combining neddylation inhibition with ASCT2 blockade to counter metabolic adaptation in breast cancer.

8489 records 1/566 page Next 12345 下5页 Last page